Silva Anjana, Kuruppu Sanjaya, Othman Iekhsan, Goode Robert J A, Hodgson Wayne C, Isbister Geoffrey K
Monash Venom Group, Department of Pharmacology, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia.
Department of Parasitology, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, 50008, Sri Lanka.
Neurotox Res. 2017 Jan;31(1):11-19. doi: 10.1007/s12640-016-9650-4. Epub 2016 Jul 11.
Russell's vipers are snakes of major medical importance in Asia. Russell's viper (Daboia russelii) envenoming in Sri Lanka and South India leads to a unique, mild neuromuscular paralysis, not seen in other parts of the world where the snake is found. This study aimed to identify and pharmacologically characterise the major neurotoxic components of Sri Lankan Russell's viper venom. Venom was fractionated using size exclusion chromatography and reverse-phase high-performance liquid chromatography (RP-HPLC). In vitro neurotoxicities of the venoms, fractions and isolated toxins were measured using chick biventer and rat hemidiaphragm preparations. A phospholipase A (PLA) toxin, U1-viperitoxin-Dr1a (13.6 kDa), which constitutes 19.2 % of the crude venom, was isolated and purified using HPLC. U1-viperitoxin-Dr1a produced concentration-dependent in vitro neurotoxicity abolishing indirect twitches in the chick biventer nerve-muscle preparation, with a t of 55 ± 7 min only at 1 μM. The toxin did not abolish responses to acetylcholine and carbachol indicating pre-synaptic neurotoxicity. Venom, in the absence of U1-viperitoxin-Dr1a, did not induce in vitro neurotoxicity. Indian polyvalent antivenom, at the recommended concentration, only partially prevented the neurotoxic effects of U1-viperitoxin-Dr1a. Liquid chromatography mass spectrometry analysis confirmed that U1-viperitoxin-Dr1a was the basic S-type PLA toxin previously identified from this venom (NCBI-GI: 298351762; SwissProt: P86368). The present study demonstrates that neurotoxicity following Sri Lankan Russell's viper envenoming is primarily due to the pre-synaptic neurotoxin U1-viperitoxin-Dr1a. Mild neurotoxicity observed in severely envenomed Sri Lankan Russell's viper bites is most likely due to the low potency of U1-viperitoxin-Dr1a, despite its high relative abundance in the venom.
罗素蝰蛇是亚洲具有重要医学意义的蛇类。在斯里兰卡和印度南部,罗素蝰蛇(Daboia russelii)的毒液会导致一种独特的、轻微的神经肌肉麻痹,而在世界其他发现这种蛇的地区则未见此种情况。本研究旨在鉴定并从药理学角度表征斯里兰卡罗素蝰蛇毒液的主要神经毒性成分。使用尺寸排阻色谱法和反相高效液相色谱法(RP-HPLC)对毒液进行分离。利用鸡双腹肌和大鼠半膈肌标本测定毒液、各组分及分离毒素的体外神经毒性。一种磷脂酶A(PLA)毒素,U1-蝰蛇毒素-Dr1a(13.6 kDa),占粗毒液的19.2%,通过HPLC进行分离和纯化。U1-蝰蛇毒素-Dr1a在体外产生浓度依赖性神经毒性,可消除鸡双腹肌神经-肌肉标本中的间接抽搐,仅在1μM时t为55±7分钟。该毒素并未消除对乙酰胆碱和卡巴胆碱的反应,表明其具有突触前神经毒性。在没有U1-蝰蛇毒素-Dr1a的情况下,毒液不会诱导体外神经毒性。印度多价抗蛇毒血清在推荐浓度下只能部分预防U1-蝰蛇毒素-Dr1a的神经毒性作用。液相色谱-质谱分析证实U1-蝰蛇毒素-Dr1a是先前从这种毒液中鉴定出的碱性S型PLA毒素(NCBI-GI:298351762;SwissProt:P86368)。本研究表明,斯里兰卡罗素蝰蛇毒液中毒后的神经毒性主要归因于突触前神经毒素U1-蝰蛇毒素-Dr1a。在严重中毒的斯里兰卡罗素蝰蛇咬伤中观察到的轻微神经毒性很可能是由于U1-蝰蛇毒素-Dr1a的效力较低,尽管其在毒液中的相对丰度较高。